Adicet Bio
Adicet Bio is a biotechnology company creating immune cell therapies for treating cancer and other diseases.
2
Funding Rounds
$160.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ba****** Sa*** | - | - | - |
| Ca** L. Go**** | - | - | - |
| An**** Si****** (i******** | - | - | - |
| Je***** A. Ch********* | - | - | - |
| St*** Du*** | - | - | - |
| Mi***** G. Ka****** | - | - | - |
| Ch** Sc*** | - | - | |
| Ay* Ja******** | - | - | - |
Funding series
Funding Series Analysis
The company Adicet Bio has raised a total of $80m in funding over 2 rounds.
Key Insights:
- Adicet Bio Series B round, October 2019: $80m
- Adicet Bio funding round, October 2019: $80m
Adicet Bio Series B round, October 2019
$80m
Adicet Bio funding round, October 2019
$80m
Industries
Adicet Bio is active in the following industries:
- Biomedical engineering
- T cell
- Biopharmaceutical
- Cancer
- Technology
- Biology
- Biotechnology
- Internal medicine
- Healthcare
- Regenerative medicine
- Medicine
- Immunotherapy
- Cancer immunotherapy
- Oncology
- Cell therapy
- Allogeneic cell therapy
- Engineering